Matches in Nanopublications for { ?s ?p "[B- and mantle-cell lymphomas, chronic myeloid leukaemia, and multiple myeloma, however, express abnormally high levels of MCL1, contributing to chemoresistance and disease relapse.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 5 of
5
with 100 items per page.
- NP450785.RATE4hYSl-GAemag-HlBMdW1j9fllaUsnPwLIBAb9DYA4130_assertion description "[B- and mantle-cell lymphomas, chronic myeloid leukaemia, and multiple myeloma, however, express abnormally high levels of MCL1, contributing to chemoresistance and disease relapse.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP450785.RATE4hYSl-GAemag-HlBMdW1j9fllaUsnPwLIBAb9DYA4130_provenance.
- NP453258.RAKS6EeN5tDR92IKQRK7CxX4Yv7uhaj97oRqH0uGhgt_8130_assertion description "[B- and mantle-cell lymphomas, chronic myeloid leukaemia, and multiple myeloma, however, express abnormally high levels of MCL1, contributing to chemoresistance and disease relapse.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP453258.RAKS6EeN5tDR92IKQRK7CxX4Yv7uhaj97oRqH0uGhgt_8130_provenance.
- assertion description "[B- and mantle-cell lymphomas, chronic myeloid leukaemia, and multiple myeloma, however, express abnormally high levels of MCL1, contributing to chemoresistance and disease relapse.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP782630.RApHi_66AiwlTyqyuXRNrj0KYVa__TJztpDvQ67BjfcfE130_assertion description "[B- and mantle-cell lymphomas, chronic myeloid leukaemia, and multiple myeloma, however, express abnormally high levels of MCL1, contributing to chemoresistance and disease relapse.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP782630.RApHi_66AiwlTyqyuXRNrj0KYVa__TJztpDvQ67BjfcfE130_provenance.
- NP549035.RAqSvZ14PHZBzbWMeoSoIMnpXPNzeKXnpgriq6YgNIsaE130_assertion description "[B- and mantle-cell lymphomas, chronic myeloid leukaemia, and multiple myeloma, however, express abnormally high levels of MCL1, contributing to chemoresistance and disease relapse.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP549035.RAqSvZ14PHZBzbWMeoSoIMnpXPNzeKXnpgriq6YgNIsaE130_provenance.